These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7321343)

  • 41. Risk factors in calcium stone disease of the urinary tract.
    Robertson WG; Peacock M; Heyburn PJ; Marshall DH; Clark PB
    Br J Urol; 1978 Dec; 50(7):449-54. PubMed ID: 37975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic evaluation of patients with stone disease.
    Tiselius HG
    Urol Int; 1997; 59(3):131-41. PubMed ID: 9428428
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of cola consumption on urinary biochemical and physicochemical risk factors associated with calcium oxalate urolithiasis.
    Rodgers A
    Urol Res; 1999; 27(1):77-81. PubMed ID: 10092157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Studies on distribution of inorganic elements in urinary stones by electron probe X-ray microanalyser. Report 1. Calcium oxalate stone and calcium oxalate and calcium phosphate stone (author's transl)].
    Kimura Y
    Nihon Hinyokika Gakkai Zasshi; 1979 Nov; 70(11):1232-54. PubMed ID: 529651
    [No Abstract]   [Full Text] [Related]  

  • 45. The influence of weather conditions on urolithiasis.
    Dal Moro F
    J Pediatr Urol; 2014 Jun; 10(3):573. PubMed ID: 24342503
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical manifestations of calcium oxalate monohydrate and dihydrate urolithiasis.
    Koide T; Itatani H; Yoshioka T; Ito H; Namiki M; Nakano E; Okuyama A; Takemoto M; Sonoda T
    J Urol; 1982 Jun; 127(6):1067-9. PubMed ID: 7087010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk formulas in calcium oxalate urolithiasis.
    Tiselius HG
    World J Urol; 1997; 15(3):176-85. PubMed ID: 9228725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nutritional aspects of urolithiasis.
    Ringsdorf WM; Cheraskin E
    South Med J; 1981 Jan; 74(1):41-3, 46. PubMed ID: 7006092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Endocrinological studies on pathogenesis on urolithiasis. III. Calcium metabolism and parathyroid function of calcium urolithiasis (author's transl)].
    Kohri K
    Nihon Hinyokika Gakkai Zasshi; 1980 Nov; 71(11):1335-48. PubMed ID: 6257962
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro system for calcium stone formation: the constant composition model.
    Nancollas GH; Singh RP
    Contrib Nephrol; 1987; 58():49-58. PubMed ID: 3691147
    [No Abstract]   [Full Text] [Related]  

  • 51. Zinc, copper and oxalocalcic urolithiasis.
    Grases F; Ruiz J; Costa-Bauzá A; Coll R; Conte A
    Urol Int; 1993; 50(4):205-8. PubMed ID: 8506591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between experimentally induced crystalluria and relative supersaturation of various stone salts in rats.
    Khan SR; Finlayson B; Thomas WC; Hackett RL
    Urol Res; 1984; 12(6):271-3. PubMed ID: 6523649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A possible etiological role for ascorbate in calculi formation.
    Chalmers AH; Cowley DM; Brown JM
    Clin Chem; 1986 Feb; 32(2):333-6. PubMed ID: 3943193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology, Pathogenesis and diagnosis of calcium oxalate urolithiasis.
    Vahlensieck EW; Bach D; Hesse A; Strenge A
    Int Urol Nephrol; 1982; 14(4):333-47. PubMed ID: 7182367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uromucoids and urinary stone formation.
    Hallson PC; Rose GA
    Lancet; 1979 May; 1(8124):1000-2. PubMed ID: 86719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.
    Grases F; Costa-Bauzá A; March JG; Masárová L
    Urol Res; 1991; 19(6):375-80. PubMed ID: 1759332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Separate examinations on core and shell of urinary calculi.
    Schubert G; Brien G; Bick C
    Urol Int; 1983; 38(2):65-9. PubMed ID: 6845564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Morphological studies on the formation of oxalate stones (author's transl)].
    Schneider HJ; Berg W; Hesse A
    Zentralbl Allg Pathol; 1977; 121(4-5):473-80. PubMed ID: 919830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of stone formation: role of promoters and inhibitors.
    Fleisch H
    Scand J Urol Nephrol Suppl; 1980; 53():53-66. PubMed ID: 7010571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular and molecular gateways to urolithiasis: a new insight.
    Dal Moro F; Mancini M; Tavolini IM; De Marco V; Bassi P
    Urol Int; 2005; 74(3):193-7. PubMed ID: 15812202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.